Switch to:
More From Other Websites
ETFs with exposure to Mylan NV : January 17, 2017 Jan 17 2017
CVS takes on Mylan’s EpiPen with much cheaper version of an alternative Jan 15 2017
Examining Volkswagen and Fiat Chrysler's Emissions Cheating Scandals Jan 13 2017
Fifth Street Asset Management, Cray, CVS Health, Mylan and Impax Laboratories highlighted as Zacks... Jan 13 2017
Mylan’s Recent Commercial and Product Developments Jan 13 2017
Mylan NV breached its 50 day moving average in a Bearish Manner : MYL-US : January 13, 2017 Jan 13 2017
Blog Coverage Expensive EpiPen Proves Costly for Mylan as Cigna Drops it from Coverage List; Opts... Jan 13 2017
Mylan’s Profit Margins: What Made Them Change? Jan 13 2017
Pharma Stock Roundup: Trump Targets Pharma Again, Merck Up on Keytruda News Jan 13 2017
Business Watch Jan 13 2017
UPDATE 1-CVS slashes price of Impax's EpiPen rival Jan 12 2017
CVS slashes price of Impax's emergency allergy shot Jan 12 2017
Mylan Crushed by Trump, Cigna and CVS -- All In Two Days Jan 12 2017
[$$] Cigna Drops EpiPen Coverage for Generic Jan 12 2017
Pharma company executives debate drug pricing increases Jan 12 2017
CVS Debuts Cheap EpiPen Alternative Jan 12 2017
Mylan CEO Heather Bresch says caps on drug price increases won’t work Jan 12 2017
CVS Is the Latest to Rock Mylan's EpiPen Empire Jan 12 2017
Mylan’s Specialty Segment: The Effect of Falling EpiPen Sales Jan 12 2017
CVS generic competitor to EpiPen, sold at a 6th the price Jan 12 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK